Glimepiride/pioglitazone

Latanoprost is the isopropyl ester of 17-phenyl-13,14-dihydro PGF2&alpha. It is a prodrug form of the free acid, which is a potent agonist of the FP receptor in the eye.

Latanoprost is the isopropyl ester of 17-phenyl-13,14-dihydro PGF2&alpha. It is a prodrug form of the free acid, which is a potent agonist of the FP receptor in the eye.

Latanoprost (free acid) is a metabolite of Latanoprost, an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug. Latanoprost is an isopropyl ester, a prodrug form which is converted to latanoprost (free

Latanoprost (free acid) is a metabolite of Latanoprost, an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug. Latanoprost is an isopropyl ester, a prodrug form which is converted to latanoprost (free

A potent inhibitor of FTase, blocking farnesylation of H-Ras, N-Ras, and K-Ras4B with IC₅₀ values of 0.8, 1.2, and 2.0 nM, respectively displays over 50,000-fold selectivity for FTase over geranylgeranyltransferase I.

An RXR ligand.

An RXR ligand.

An RXR ligand.

Competitive melatonin receptor antagonist.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

A potent, selective antagonist of the GPR55 receptor (IC₅₀ = 221 nM).